We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-3.07%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$46.8B
AUM Growth
+$933M
(+2%)
Cap. Flow
+$2.08B
Cap. Flow
% of AUM
4.45%
Top 10 Holdings %
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.31% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Inovio Pharmaceuticals
INO
$69M
| $118K | ﹤0.01% |
+72,364
| New | +$145K |
|
2877
Liberty Latin America Class C
LILAK
$1.64B
| $117K | ﹤0.01% |
20,800
+5,070
| +32% | +$30.8K |
|
2878
indie Semiconductor
INDI
$854M
| $117K | ﹤0.01% |
57,368
-38,062
| -40% | -$132K |
|
|
OKUR
2879
OnKure Therapeutics
OKUR
$168M
| $117K | ﹤0.01% |
+27,148
| New | +$153K |
|
|
AARD
2880
Aardvark Therapeutics
AARD
$173M
| $116K | ﹤0.01% |
+15,424
| New | +$173K |
|
|
MURA
2881
DELISTED
Mural Oncology
MURA
| $115K | ﹤0.01% |
91,624
+26,474
| +41% | +$96.5K |
|
2882
Latham Group
SWIM
$880M
| $114K | ﹤0.01% |
17,674
-14,804
| -46% | -$99.6K |
|
2883
Perimeter Solutions
PRM
$5.77B
| $113K | ﹤0.01% |
+11,222
| New | +$126K |
|
|
NOTV
2884
DELISTED
Inotiv
NOTV
| $112K | ﹤0.01% |
50,684
-21,005
| -29% | -$77.1K |
|
2885
Cullinan Oncology
CGEM
$1.14B
| $112K | ﹤0.01% |
14,796
-27,409
| -65% | -$263K |
|
2886
PUT
Core Scientific
CORZ
$6.75B
| $110K | ﹤0.01% |
15,200
| – | – |
|
|
NOAH
2887
Noah Holdings
NOAH
$603M
| $110K | ﹤0.01% |
+11,629
| New | +$127K |
|
2888
BARK
BARK
$101M
| $109K | ﹤0.01% |
3,908
-3,040
| -44% | -$106K |
|
2889
Lightspeed Commerce
LSPD
$1.35B
| $106K | ﹤0.01% |
12,077
-352,323
| -97% | -$4.54M |
|
2890
Microbot Medical
MBOT
$127M
| $103K | ﹤0.01% |
+68,198
| New | +$121K |
|
|
AGIG
2891
Abundia Global Impact Group
AGIG
$36.5M
| $102K | ﹤0.01% |
13,278
+7,696
| +138% | +$101K |
|
|
IMA
2892
ImageneBio Inc
IMA
$64.6M
| $102K | ﹤0.01% |
6,619
-1,779
| -21% | -$30.7K |
|
2893
Flywire
FLYW
$2.16B
| $101K | ﹤0.01% |
+10,613
| New | +$167K |
|
2894
Vertical Aerospace
EVTL
$173M
| $101K | ﹤0.01% |
+29,990
| New | +$168K |
|
2895
Clarus
CLAR
$143M
| $101K | ﹤0.01% |
26,819
-23,750
| -47% | -$107K |
|
2896
Protara Therapeutics
TARA
$232M
| $100K | ﹤0.01% |
23,590
+9,957
| +73% | +$44.5K |
|
2897
CuriosityStream
CURI
$161M
| $100K | ﹤0.01% |
37,300
-1,197
| -3% | -$2.91K |
|
2898
Algoma Steel
ASTL
$431M
| $98.7K | ﹤0.01% |
18,213
-18,387
| -50% | -$138K |
|
2899
Harvard Bioscience
HBIO
$29.2M
| $98.1K | ﹤0.01% |
17,333
+13,751
| +384% | +$176K |
|
2900
Zevia
ZVIA
$111M
| $97.9K | ﹤0.01% |
+45,307
| New | +$148K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Two Sigma Investments held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Two Sigma Investments deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- Two Sigma Investments's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- Two Sigma Investments's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- Two Sigma Investments fully exited Coinbase in Q1 2025, selling an estimated $45M.
- Two Sigma Investments's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- Two Sigma Investments opened 458 new positions and closed 453 in Q1 2025.
- Two Sigma Investments's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.